Executive record

David R. Wells

Director at HeartSciences Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:david-r-wellsVersion: public-0As of: 2026-09-30

Not yet claimed12 published Claims4 sources
  • Director

Key Claims

Biography

Over 30 years of experience in finance, operations and administrative positions. Currently CFO of Envoy Medical, Inc. (publicly traded medical device company) since August 2023. Partner of Atlas Bookkeeping, LLC (technology-based financial services firm) founded October 2022. Former CFO of ENDRA Life Sciences Inc. and GHS Investments, LLC.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. 2025 to end not publishedExecutive title: Director · Organization not publishedHSCS 10-K executive officers
  2. Dates not publishedExecutive title: Chief Financial Officer · Organization not publishedHSCS DEF 14A director slate

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. HSCS DEF 14A director slate

    sec filing · Source published: Mar 17, 2026 · Retrieved: May 16, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Audit, Nominating/Governance, Compensation · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Envoy Medical, Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chief Financial Officer · Claim reviewed: May 16, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: May 16, 2026

  2. Open source

    sec proxy · Source published: Mar 17, 2026 · Retrieved: Apr 25, 2026

    Supports 1 claim
    • Professional Role: Director at HeartSciences Inc. · Claim reviewed: May 16, 2026

  3. HSCS 10-K executive officers

    sec filing · Source published: Jul 24, 2025 · Retrieved: May 16, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at HeartSciences Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Director · Claim reviewed: May 16, 2026
    • Other Company Role: David R. Wells is also linked to Envoy Medical, Inc. as Chief Financial Officer. · Claim reviewed: May 16, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: May 16, 2026

  4. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of HeartSciences Inc. · Claim reviewed: May 16, 2026